List of Tables
Table 1. Global Hormone Disorder Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Hormone Disorder Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Hormone Disorder Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Hormone Disorder Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Hormone Disorder Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Hormone Disorder Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Hormone Disorder Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Hormone Disorder Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Hormone Disorder Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hormone Disorder Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hormone Disorder Drug, Product Type & Application
Table 12. Global Key Manufacturers of Hormone Disorder Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hormone Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormone Disorder Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hormone Disorder Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Hormone Disorder Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Hormone Disorder Drug Sales Market Share by Region (2020-2025)
Table 19. Global Hormone Disorder Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Hormone Disorder Drug Sales Market Share by Region (2026-2031)
Table 21. Global Hormone Disorder Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Hormone Disorder Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Hormone Disorder Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Hormone Disorder Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Hormone Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Hormone Disorder Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Hormone Disorder Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Hormone Disorder Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Hormone Disorder Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Hormone Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Hormone Disorder Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Hormone Disorder Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Hormone Disorder Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Hormone Disorder Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Hormone Disorder Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Hormone Disorder Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Hormone Disorder Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Hormone Disorder Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Hormone Disorder Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Hormone Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Hormone Disorder Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Hormone Disorder Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Hormone Disorder Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Hormone Disorder Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Hormone Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Hormone Disorder Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Hormone Disorder Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Hormone Disorder Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Hormone Disorder Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Hormone Disorder Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Hormone Disorder Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Hormone Disorder Drug Sales Market Share by Type (2020-2025)
Table 53. Global Hormone Disorder Drug Sales Market Share by Type (2026-2031)
Table 54. Global Hormone Disorder Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Hormone Disorder Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Hormone Disorder Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Hormone Disorder Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Hormone Disorder Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Hormone Disorder Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Hormone Disorder Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Hormone Disorder Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Hormone Disorder Drug Sales Market Share by Application (2020-2025)
Table 63. Global Hormone Disorder Drug Sales Market Share by Application (2026-2031)
Table 64. Global Hormone Disorder Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Hormone Disorder Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Hormone Disorder Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Hormone Disorder Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Hormone Disorder Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Hormone Disorder Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Teva Pharmaceutical Industries Ltd Company Information
Table 71. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 72. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Product
Table 74. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 75. Amneal Pharmaceutical Inc Company Information
Table 76. Amneal Pharmaceutical Inc Description and Business Overview
Table 77. Amneal Pharmaceutical Inc Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Amneal Pharmaceutical Inc Hormone Disorder Drug Product
Table 79. Amneal Pharmaceutical Inc Recent Developments/Updates
Table 80. Mayne Pharma Group Limited Company Information
Table 81. Mayne Pharma Group Limited Description and Business Overview
Table 82. Mayne Pharma Group Limited Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Mayne Pharma Group Limited Hormone Disorder Drug Product
Table 84. Mayne Pharma Group Limited Recent Developments/Updates
Table 85. Merck KGaA Company Information
Table 86. Merck KGaA Description and Business Overview
Table 87. Merck KGaA Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Merck KGaA Hormone Disorder Drug Product
Table 89. Merck KGaA Recent Developments/Updates
Table 90. Sanofi Company Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Sanofi Hormone Disorder Drug Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Sun Pharmaceutical Industries Ltd Company Information
Table 96. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 97. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Product
Table 99. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 100. Novartis AG Company Information
Table 101. Novartis AG Description and Business Overview
Table 102. Novartis AG Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Novartis AG Hormone Disorder Drug Product
Table 104. Novartis AG Recent Developments/Updates
Table 105. F. Hoffmann-La Roche Ltd Company Information
Table 106. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 107. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Product
Table 109. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 110. Abbott Company Information
Table 111. Abbott Description and Business Overview
Table 112. Abbott Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Abbott Hormone Disorder Drug Product
Table 114. Abbott Recent Developments/Updates
Table 115. PT. Daewoong Pharmaceutical Company Company Information
Table 116. PT. Daewoong Pharmaceutical Company Description and Business Overview
Table 117. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Product
Table 119. PT. Daewoong Pharmaceutical Company Recent Developments/Updates
Table 120. Genentech, Inc Company Information
Table 121. Genentech, Inc Description and Business Overview
Table 122. Genentech, Inc Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Genentech, Inc Hormone Disorder Drug Product
Table 124. Genentech, Inc Recent Developments/Updates
Table 125. Bausch Health Companies Inc Company Information
Table 126. Bausch Health Companies Inc Description and Business Overview
Table 127. Bausch Health Companies Inc Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Bausch Health Companies Inc Hormone Disorder Drug Product
Table 129. Bausch Health Companies Inc Recent Developments/Updates
Table 130. Lilly Company Information
Table 131. Lilly Description and Business Overview
Table 132. Lilly Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Lilly Hormone Disorder Drug Product
Table 134. Lilly Recent Developments/Updates
Table 135. Ipsen Pharma Company Information
Table 136. Ipsen Pharma Description and Business Overview
Table 137. Ipsen Pharma Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Ipsen Pharma Hormone Disorder Drug Product
Table 139. Ipsen Pharma Recent Developments/Updates
Table 140. Ferring B.V Company Information
Table 141. Ferring B.V Description and Business Overview
Table 142. Ferring B.V Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Ferring B.V Hormone Disorder Drug Product
Table 144. Ferring B.V Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Hormone Disorder Drug Distributors List
Table 148. Hormone Disorder Drug Customers List
Table 149. Hormone Disorder Drug Market Trends
Table 150. Hormone Disorder Drug Market Drivers
Table 151. Hormone Disorder Drug Market Challenges
Table 152. Hormone Disorder Drug Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hormone Disorder Drug
Figure 2. Global Hormone Disorder Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hormone Disorder Drug Market Share by Type: 2024 & 2031
Figure 4. Growth Hormone Stimulator Product Picture
Figure 5. Growth Hormone Inhibitor Product Picture
Figure 6. Global Hormone Disorder Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Hormone Disorder Drug Market Share by Application: 2024 & 2031
Figure 8. Dwarfism
Figure 9. Gigantism
Figure 10. Other
Figure 11. Global Hormone Disorder Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Hormone Disorder Drug Market Size (2020-2031) & (US$ Million)
Figure 13. Global Hormone Disorder Drug Sales (2020-2031) & (K Units)
Figure 14. Global Hormone Disorder Drug Average Price (US$/Unit) & (2020-2031)
Figure 15. Hormone Disorder Drug Report Years Considered
Figure 16. Hormone Disorder Drug Sales Share by Manufacturers in 2024
Figure 17. Global Hormone Disorder Drug Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Hormone Disorder Drug Players: Market Share by Revenue in Hormone Disorder Drug in 2024
Figure 19. Hormone Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Hormone Disorder Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Hormone Disorder Drug Sales Market Share by Country (2020-2031)
Figure 22. North America Hormone Disorder Drug Revenue Market Share by Country (2020-2031)
Figure 23. United States Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Hormone Disorder Drug Sales Market Share by Country (2020-2031)
Figure 26. Europe Hormone Disorder Drug Revenue Market Share by Country (2020-2031)
Figure 27. Germany Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Hormone Disorder Drug Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Hormone Disorder Drug Revenue Market Share by Region (2020-2031)
Figure 34. China Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Hormone Disorder Drug Sales Market Share by Country (2020-2031)
Figure 42. Latin America Hormone Disorder Drug Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Hormone Disorder Drug Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Hormone Disorder Drug Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Hormone Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Hormone Disorder Drug by Type (2020-2031)
Figure 52. Global Revenue Market Share of Hormone Disorder Drug by Type (2020-2031)
Figure 53. Global Hormone Disorder Drug Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Hormone Disorder Drug by Application (2020-2031)
Figure 55. Global Revenue Market Share of Hormone Disorder Drug by Application (2020-2031)
Figure 56. Global Hormone Disorder Drug Price (US$/Unit) by Application (2020-2031)
Figure 57. Hormone Disorder Drug Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
